Transforming Growth Factor β2 Is a Neuronal Death-Inducing Ligand for Amyloid-β Precursor Protein

REFERENCES

• Amara, F. M., A. Junaid, R. R. Clough, and B. Liang. 1999. TGF-β1, regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res. Mol. Brain Res. 71:42–49.
   PubMedGoogle Scholar
• Armstrong, R. A. 1994. Differences in beta-amyloid (β/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci. Lett. 169:133–136.
   PubMedGoogle Scholar
• Bodmer, S., M. B. Podlisny, D. J. Selkoe, I. Heid, and A. Fontana. 1990. Transforming growth factor-β bound to soluble derivatives of the β amyloid precursor protein of Alzheimer's disease. Biochem. Biophys. Res. Commun. 171:890–897.
   PubMed Web of Science ®Google Scholar
• Cairns, N. J., A. Chadwick, P. L. Lantos, R. Levy, and M. N. Rossor. 1993. βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci. Lett. 149:137–140.
   PubMedGoogle Scholar
• Chalazonitis, A., J. Kalberg, D. R. Twardzik, R. S. Morrison, and J. A. Kessler. 1992. Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152:121–132.
   PubMed Web of Science ®Google Scholar
• Chao, C. C., S. Hu, W. H. Frey, T. A. Ala, W. W. Tourtellotte, and P. K. Peterson. 1994. Transforming growth factor β in Alzheimer's disease. Clin. Diagn. Lab. Immunol. 1:109–110.
   PubMedGoogle Scholar
• Cheifetz, S., J. A. Weatherbee, M. L. Tsang, J. K. Anderson, J. E. Mole, R. Lucas, and J. Massagué. 1987. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409–415.
   PubMed Web of Science ®Google Scholar
• Citron, M., T. Oltersdorf, C. Haass, L. McConlogue, A. Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg, and D. J. Selkoe. 1992. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672–674.
   PubMed Web of Science ®Google Scholar
• Flanders, K. C., G. Lüdecke, S. Engels, D. S. Cissel, A. B. Roberts, P. Kondaiah, R. Lafayatis, M. B. Sporn, and K. Unsicker. 1991. Localizations and actions of transforming growth factor-βs in the embryonic nervous system. Development 113:183–191.
   PubMed Web of Science ®Google Scholar
• Flanders, K. C., C. F. Lippa, T. W. Smith, D. A. Pollen, and M. B. Sporn. 1995. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology 45:1561–1569.
   PubMed Web of Science ®Google Scholar
• Gelinas, D. S., K. DaSilva, D. Fenili, P. St. George-Hyslop, and J. McLaurin. 2004. Immunotherapy for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101:14657–14662.
   PubMed Web of Science ®Google Scholar
• Gray, C. W., and A. J. Patel. 1993. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes. Brain Res. Mol. Brain Res. 19:251–256.
   PubMedGoogle Scholar
• Hardy, J., and D. J. Selkoe. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353–356.
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., T. Niikura, Y. Ito, and I. Nishimoto. 2000. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J. Biol. Chem. 275:34541–34551.
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, K. Terashita, S. Aiso, H. Ichijo, and I. Nishimoto. 2003. The cytoplasmic domain of Alzheimer's amyloid precursor protein causes sustained ASK1/JNK-mediated neurotoxic signal via dimerization. J. Pharmacol. Exp. Ther. 306:889–902.
   PubMed Web of Science ®Google Scholar
• Jennings, M. T., and J. A. Pietenpol. 1998. The role of transforming growth factor β in glioma progression. J. Neurooncol. 36:123–140.
   PubMed Web of Science ®Google Scholar
• Kang, J., H. G. Lemaire, A. Unterbeck, J. M. Salbaum, C. L. Masters, K. H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733–736.
   PubMed Web of Science ®Google Scholar
• Kawasumi, M., T. Chiba, M. Yamada, M. Miyamae-Kaneko, M. Matsuoka, J. Nakahara, T. Tomita, T. Iwatsubo, S. Kato, S. Aiso, and I. Nishimoto, and K. Kouyama. 2004. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Eur. J. Neurosci. 19:2826–2838.
   PubMedGoogle Scholar
• Krieglstein, K., C. Suter-Crazzolara, W. H. Fischer, and K. Unsicker. 1995. TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14:736–742.
   PubMed Web of Science ®Google Scholar
• Krieglstein, K., S. Richter, L. Farkas, N. Schuster, N. Dunker, R. W. Oppenheim, and K. Unsicker. 2000. Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death. Nat. Neurosci. 3:1085–1090.
   PubMed Web of Science ®Google Scholar
• Lesné, S., F. Docagne, C. Gabrie, G. Liot, D. K. Lahiri, L. Buée, L. Plawinski, A. Delacourte, E. T. MacKenzie, A. Buisson, and D. Vivien. 2003. Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice. J. Biol. Chem. 278:18408–18418.
   PubMedGoogle Scholar
• Liao, Y.-F., B. J. Wang, H. T. Cheng, L. H. Kuo, and M. S. Wolf. 2004. Tumor necrosis factor-α, interleukin-1β, and interferon-γ stimulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK Pathway. J. Biol. Chem. 279:49523–49532.
   PubMed Web of Science ®Google Scholar
• Lippa, C. F., K. C. Flanders, E. S. Kim, and S. Croul. 1998. TGF-β receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy. Neurobiol. Aging 19:527–533.
   PubMedGoogle Scholar
• Lund, L. R., A. Riccio, P. A. Andreasen, L. S. Nielsen, P. Kristensen, M. Laiho, O. Saksela, F. Blasi, and K. Dano. 1987. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 6:1281–1286.
   PubMed Web of Science ®Google Scholar
• Luo, J. J., W. Wallace, T. Riccioni, D. K. Ingram, G. S. Roth, and J. W. Kusiak. 1999. Death of PC12 cells and hippocampal neurons induced by adenoviral-mediated FAD human amyloid precursor protein gene expression. J. Neurosci. Res. 55:629–642.
   PubMed Web of Science ®Google Scholar
• Lyman, S. D., L. James, T. Vanden Bos, P. de Vries, K. Brasel, B. Gliniak, L. T. Hollingsworth, K. S. Picha, H. J. McKenna, R. R. Splett, F. A. Fletcher, E. Maraskovsky, D. E. Williams, and M. P. Beckman. 1993. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157–1167.
   PubMed Web of Science ®Google Scholar
• Martinou, J. C., A. Le Van Thai, A Valette, and M. J. Weber. 1990. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture. Brain Res. Dev. Brain Res. 52:175–181.
   PubMedGoogle Scholar
• Massagué, J., J. Andres, L. Attisano, S. Cheifetz, F. Lopez-Casillas, M. Ohtsuki, and J. L. Wrana. 1992. TGF-β receptors. Mol. Reprod. Dev. 32:99–104.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Massagué, J., S. W. Blain, and R. S. Lo. 2000. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295–309.
   PubMed Web of Science ®Google Scholar
• McPhie, D. L., R. Coopersmith, A. Hines-Peralta, Y. Chen, K. J. Ivins, S. P. Manly, M. R. Kozlowski, K. A. Nevé, and R. L. Nevé. 2003. DNA synthesis and neuronal apoptosis caused by familial Alzheimer's disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 23:6914–6927.
   PubMed Web of Science ®Google Scholar
• Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
   PubMed Web of Science ®Google Scholar
• Nevé, R. L., D. L. McPhie, and Y. Chen. 2000. Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Res. 886:54–66.
   PubMedGoogle Scholar
• Niikura, T., M. Yamada, T. Chiba, S. Aiso, M. Matsuoka, and I. Nishimoto. 2004. Characterization of V642I-AβPP-induced cytotoxicity in primary neurons. J. Neurosci. Res. 77:54–62.
   PubMed Web of Science ®Google Scholar
• Nishimoto, I., T. Okamoto, Y. Matsuura, S. Takahashi, T. Okamoto, Y. Murayama, and E. Ogata. 1993. Alzheimer amyloid protein precursor complexes with brain GTP binding protein Go. Nature 362:75–79.
   PubMed Web of Science ®Google Scholar
• Peress, N. S., and E. Perillo. 1995. Differential expression of TGF-β 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54:802–811.
   PubMed Web of Science ®Google Scholar
• Poulson, K. T., A. P. Armanini, R. D. Klein, M. A. Hynes, H. S. Phillips, and A. Rosenthal. 1994. TGF-β2 and TGF-β3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13:1245–1252.
   PubMed Web of Science ®Google Scholar
• Pratt, B. M., and J. M. McPherson. 1997. TGF-β in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8:267–292.
   PubMedGoogle Scholar
• Rohn, T. T., K. J. Ivins, B. A. Bahr, C. W. Cotman, and D. H. Cribbs. 2000. A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J. Neurochem. 74:2331–2342.
   PubMed Web of Science ®Google Scholar
• Rotzer, D., M. Roth, M. Lutz, D. Lindemann, W. Sebald, and P. Knaus. 2000. Type III TGF-β receptor-independent signalling of TGF-β2 via TβRII-B, an alternatively spliced TGF-β type II receptor. EMBO J. 20:480–490.
   Google Scholar
• Santiago-Garcia, J., J. Mas-Oliva, T. L. Innerarity, and R. E. Pitas. 2001. Secreted forms of the amyloid-β precursor protein are ligands for the class A scavenger receptor. J. Biol. Chem. 276:30655–30661.
   PubMedGoogle Scholar
• Schuster, N., and K. Krieglstein. 2002. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 307:1–14.
   PubMed Web of Science ®Google Scholar
• Sudo, H., Y. Hashimoto, T. Niikura, Z. Shao, T. Yasukawa, Y. Ito, M. Yamada, M. Hata, T. Hiraki, M. Kawasumi, K. Kouyama, and I. Nishimoto. 2001. Secreted Aβ does not mediate neurotoxicity by antibody-stimulated amyloid precursor protein. Biochem. Biophys. Res. Commun. 282:548–556.
   PubMedGoogle Scholar
• Suzuki, N., T. T. Cheung, X. D. Cai, A. Odaka, L. Otvos, Jr., C. Eckman, T. E. Golde, and S. G. Younkin. 1994. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264:1336–1340.
   PubMed Web of Science ®Google Scholar
• ten Dijke, P., and C. S. Hill. 2004. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29:265–273.
   PubMed Web of Science ®Google Scholar
• Tomita, T., K. Maruyama, T. C. Saido, H. Kume, K. Shinozaki, S. Tokuhiro, A. Capell, J. Walter, J. Grunberg, C. Haass, T. Iwatsubo, and K. Obata. 1997. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94:2025–2030.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray, T., E. Masliah, M. Mallory, L. McConlogue, K. Johnson-Wood, C. Lin, and L. Mucke. 1997. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 389:603–606.
   PubMed Web of Science ®Google Scholar
• Yamatsuji, T., T. Okamoto, S. Takeda, Y. Murayama, N. Tanaka, and I. Nishimoto. 1996. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J. 15:498–509.
   PubMed Web of Science ®Google Scholar
• Yamatsuji, T., T. Okamoto, S. Takeda, H. Fukumoto, T. Iwatsubo, N. Suzuki, A. Asami-Odaka, S. Ireland, T. Kinane, U. Giambarella, and I. Nishimoto. 1996. G protein-mediated neuronal DNA fragmentation by familial Alzheimer's disease associated V642 mutants of APP. Science 272:1349–1352.
   PubMed Web of Science ®Google Scholar
• Zhao, B., F. J. Chrest, W. E. Horton, Jr., S. S. Sisodia, and J. W. Kusiak. 1997. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J. Neurosci. Res. 47:253–263.
   PubMed Web of Science ®Google Scholar